This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0450U only for M–inSight® Patient Definition Assay from Corgenix Clinical Laboratory. The test, on a blood serum specimen, uses liquid chromatography with tandem mass spectrometry (LC–MS/MS) to identify specific protein pieces, known as clonotypic peptides, that come from cells in a patient with multiple myeloma. The results are reported as baseline presence or absence of detectable clonotypic peptides.
For clinical responsibility, terminology, tips and additional info
start codify free trial.